Institutional investors purchased a net $447.5 thousand shares of HPTX during the quarter ended September 2014 and now own 58.94% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARMISTICE CAPITAL LLC Bought 434.0 Thousand shares of Hyperion Therapeutics Inc
BLACKROCK FUND ADVISORS Bought 373.3 Thousand shares of Hyperion Therapeutics Inc